Showing results (881-890 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|January 17, 2009
Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increasedTakashi Makita, Tetsuya Aiba, Yuki Izuwa, et al.Biopharmaceutics & Drug Disposition|April 27, 2004
The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body modelEyal Sobol, Meir BialerBiopharmaceutics & Drug Disposition|September 21, 2004
Pharmacokinetics, metabolism and excretion of intravenous [l4C]-palonosetron in healthy human volunteersRandall Stoltz, Simona Parisi, Ajit Shah, et al.Biopharmaceutics & Drug Disposition|March 16, 2005
Evaluation of the effect of candesartan cilexetil on the steady-state pharmacokinetics of tacrolimus in renal transplant patientsFrank Pietruck, Gerhard Kiel, Manfred Birkel, et al.Biopharmaceutics & Drug Disposition|August 2, 2005
Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage formsShrutidevi Agrawal, Ramesh PanchagnulaBiopharmaceutics & Drug Disposition|October 24, 2007
Decreased biliary excretion of tributylmethyl ammonium in cholestyramine pretreated rats due to reduced formation of ion-pair complexes with hepatic bile saltsM K Choi, I S Song, D D Kim, et al.Biopharmaceutics & Drug Disposition|November 21, 2007
Pharmacokinetics of phenytoin and its metabolite, 4'-HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocinYu C Kim, Hee E Kang, Myung G LeeBiopharmaceutics & Drug Disposition|April 1, 1991
Pharmacokinetic studies of the nitroglycerin metabolites, 1,2- and 1,3- glyceryl dinitrates, in the ratD T Lau, M Gumbleton, C Labisch, et al.Biopharmaceutics & Drug Disposition|November 6, 2008
Cloning of the dog bile salt export pump (BSEP; ABCB11) and functional comparison with the human and rat proteinsHikaru Yabuuchi, Kenji Tanaka, Miyako Maeda, et al.Biopharmaceutics & Drug Disposition|June 30, 2009
Tissue distribution of the novel DPP-4 inhibitor BI 1356 is dominated by saturable binding to its target in ratsHolger Fuchs, Rudolf Binder, Andreas GreischelPageof 214